Natural inhibitors of tumour necrosis factor-α production, secretion and function

被引:40
|
作者
Habtemariam, S [1 ]
机构
[1] Univ Greenwich, Sch Chem & Life Sci, London SE18 6PF, England
关键词
TNF; natural inhibitors; adhesion molecules; NF-kappa B; cAMP; inflammation; cytotoxicity;
D O I
10.1055/s-2000-8660
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tumour necrosis factor-alpha (TNF), originally discovered by its antitumor activity, is one of the most pleotropic cytokines acting as a host defence factor in immunologic and inflammatory responses. Although the antitumour activity and mediation of inflammation by TNF could be beneficial to the host, unregulated TNF is now known to be the basis for development of various diseases including septic shock, the wasting disease, cachexia, and various inflammatory and/or autoimmune diseases. With an attempt to find potential therapeutic agents for TNF-mediated diseases, research during the last decade has led in the identification of well over one hundred natural inhibitors of either TNF production/secretion or function. This review summarises the structures, mechanism of action and therapeutic potential of these natural products.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 50 条
  • [41] The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritisA budget impact analysis
    Jan Sørensen
    Lis S. Andersen
    PharmacoEconomics, 2005, 23 : 289 - 298
  • [42] The Potential Effect of the Tumour Necrosis Factor-α Inhibitors on Vitamin D Status in Psoriatic Patients
    Ganzetti, Giulia
    Campanati, Anna
    Scocco, Vitangelo
    Brugia, Marina
    Tocchini, Massimo
    Liberati, Giulia
    Giulio-dori, Katia
    Brisigotti, Valerio
    Offidani, Annamaria
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (06) : 715 - 717
  • [43] The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis -: A budget impact analysis
    Sorensen, J
    Andersen, LS
    PHARMACOECONOMICS, 2005, 23 (03) : 289 - 298
  • [44] Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents
    Mansouri, Y.
    Martin-Clavijo, A.
    Newsome, P.
    Kaur, M. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (04) : 916 - 918
  • [45] Drug Survival of Tumour Necrosis Factor-α Inhibitors in Patients with Ankylosing Spondylitis and Axial Spondyloarthritis
    Chu, Raymond
    Chow, Andrew
    Soucy, Elaine
    Bhatt, Palki
    Got, Tiffany
    Hong, Daniel
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1331 - 1331
  • [46] The evaluation of inhibitive effectiveness of the tumour necrosis factor-αα converting enzyme selective inhibitors by HPLC
    Zhao, Yunbin
    Yu, Jin
    Gu, Jiuling
    Huang, Wei
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2011, 26 (02) : 181 - 187
  • [48] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [49] Trypsin induces tumour necrosis factor-α secretion from a human leukemic mast cell line
    Kang, OH
    Jeong, HJ
    Kim, DK
    Choi, SC
    Kim, TH
    Nah, YH
    Kim, HM
    Lee, YM
    CELL BIOCHEMISTRY AND FUNCTION, 2003, 21 (02) : 161 - 167
  • [50] Pyridostigmine ameliorates preeclamptic features in pregnant rats by inhibiting tumour necrosis factor-α synthetsis and antagonizing tumour necrosis factor-α-related effects
    Zibrila, Abdoulaye Issotina
    Wang, Zheng
    Ali, Md Ahasan
    Osei, James Ampofo
    Sun, Yuyao
    Zafar, Salman
    Liu, Kaili
    Li, Chunfang
    Kang, Yuming
    Liu, Jinjun
    JOURNAL OF HYPERTENSION, 2021, 39 (09) : 1774 - 1789